期刊文献+

ERCC1 mRNA及P53表达对局部晚期宫颈癌治疗决策的影响及关联性研究 被引量:1

Studying roles and relation of expression of ERCC1 mRNA and P53 genein to locally advanced cervical cancer neoadjuvant chemothearapy
原文传递
导出
摘要 目的探讨局部晚期宫颈癌(LACC)组织中ERCC1 mRNA及P53蛋白表达与新辅助化疗(NACT)敏感性及预后的关系。方法采集60例病例,在NACT前分别应用RT—PCR(逆转录聚合酶链反应)技术及免疫组化SP方法检测ERCC1mRNA和P53蛋白的表达。结果 60例患者中,有效45例,有效率为75.00%。患者年龄、病理分级及类型与NACT疗效差异均无统计学意义(P﹥0.05)。局部晚期宫颈癌组织中ERCC1mRNA、P53蛋白的表达与NACT疗效有关(P〈0.05)。其中ERCC1mRNA及P53过表达均为NACT疗效的危险因素,分别[β=-1.398OR(95%CI)=0.247(0.069-0.880)],[β=-1.981,OR(95%CI)=1.375(0.903-1.519)]。术后病理结果提示具有放疗高危因素者共31例(68.9%)。二者过表达均可提示术后病理结果具有放疗高危因素(P〈0.05)。且二者表达水平呈显著正相关(r=0.275,P〈0.05)。结论 LACC组织中ERCC1mRNA及P53表达与NACT敏感性相关,并且可提示术后病理结果具有放疗高危因素,两者表达呈正相关。 Objective To investigate association between expression of ERCC1 mRNA and P53 gene with the neoadjuvant chemotherapy (NACT) response and prognosis of locally advanced cervical cancer (LACC). Methods A total of 60 biopsies from LACC patients were collected before chemotherapy in Henan Cancer Hospital. Using these paraffin embedded samples, the expression of ERCC1 mRNA was detected RT - PCR technique,and the expression of P53 protein was examined by immunohistochemistry ( IHC ). Results Our results indicate that 45 out of 60 patients demonstrated positive response to NACT, and the effective rate was 75 %. In addition, The logistic regression analysis showed that expression of ERCC1 mRNA and P53 protein was negative factors for curative effect of NACT( P 〈 0. 05 ) , whereas no correlation was found between over - expression of ERCC1 mRNA,P53 and age group ,pathological grade as well as tumor type(P 〉 0.05). Over-expression of ERCC1 mRNA was found to be positively correlated with P53 protein (P 〈 0. 05 ). Furthermore, we also found high risk group of patients accounted for 68.9% ( 35 ) , undergoing radiotherapy in the postoperative pathological results. Conclusion The over - expression of ERCC1 mRNA and P53 protein in LACC tissue is related to the resistance to NACT,which could be used to indicate whether a high risk exists based on the post- operative pathological results. In addition, expression of two markers demonstrates positive correlation.
出处 《医药论坛杂志》 2016年第1期7-10,共4页 Journal of Medical Forum
关键词 局部晚期宫颈癌 ERCC1 MRNA P53 新辅助化疗 Locally advanced cervical cancer ERCC1 mRNA P53 gene Neoadjuvant chemotherapy
  • 相关文献

参考文献19

  • 1Sardi JE, bioxadera MA, sardi JJ. neoadjuvant chemotherapy in cervical caner :a new trend [ J]. Curr Opin Obstet Gynecol, 2005,17( 1 ) :43-47.
  • 2Whitney CW, Sause W, Bundy BN, et al. Randomized compari- son of fluorouracil plus cisplatin versus hydroxyurea as an ad- junct to radiation therapy in stages ⅡB - ⅣA carcinoma of the cervix with negative para- aortic lymph nodes: a Gynecologic Oneology Group and Southwest Oncology Group Study [ J ]. J Clin Oneol, 1999, 17(5): 1339-1348.
  • 3Choi CH, Kim TJ, Lee JW, et al. Phase II study of neoadjuvant chemotherapy with mitomycin - c, vincristine and cisplatin (MVC) in patient with stages Ib2 - IIb cervical carcinoma[ J]. Gynecol Oncol,2007,104( 1 ) :64-69.
  • 4Benedetti Panici P, Bellati F,Pastore M, et al. An update in neo- adjuvant chemotherapy in cervical cancer [ J ]. Gynecol Oncol, 2007,107 ( 1 Suppl 1 ) :20-22.
  • 5Liu Y, Scheurer Me, EI - Zein R, et al. Association and interac- tions between DNA repair gene polymorphisms and adult glioma [J]. Cancer Epidemiol Biomarkers Prev, 2009,18 ( 1 ) : 204- 214.
  • 6Rosell R, Lord RV,Taron M, et al. DNA repair and cisplatin re- sistance in non - small - cell lung cancer [ J ]. Lung Cancer, 2002,38 (3) :217-227.
  • 7Fujii T, Toyooka S, Ichimura K. ERCC1 protein expression pre- dicts the response of cisplatin - based neoajuvant chemotherapy in non - small - cell lung cancer [ J ]. Lung Cancer, 2008,59 (3) :377-384.
  • 8韩冰,殷沛.Bcl-2及P53在口腔扁平苔藓及口腔鳞状细胞癌表达的研究[J].中国实用医刊,2012,39(24):24-26. 被引量:5
  • 9Zhou Y, Li N,Zhuang W, et al. P53 codon 72 polymorphism and gastric cancer: a meta - analysis of the literature [ J ]. Int J Canc- er,2007,121 (7) : 1481-1486.
  • 10妇科常见恶性肿瘤诊断与治疗规范(草案)[J].中华妇产科杂志,1998,33(11):694-704. 被引量:113

二级参考文献60

共引文献160

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部